In medical science, sometimes two
drugs with different solubilities
are simultaneously required in combination to treat various diseases.
Herein, a pH-responsive, copolymeric, antioxidant, biocompatible,
and chemically crosslinked network gel is prepared to explore its
capability as a matrix for controlled release of both hydrophobic
[ibuprofen (IB)] and hydrophilic [tetracycline hydrochloride (TCH)]
drugs, simultaneously. This three-dimensional β-CD-Meth-cl-(PHPMA-co-PAAc) network hydrogel is synthesized via two steps:
(I) methacrylation of β-cyclodextrin and (II) grafting of poly(hydroxypropyl
methacrylate) and poly(acrylic acid), followed by crosslinking of
poly(ethylene glycol) diacrylate onto the backbone of methacrylated
β-cyclodextrin (β-CD-Meth). The successful synthesis of
the hydrogel is confirmed using several physiochemical characterizations.
The β-CD-Meth-cl-(PHPMA-co-PAAc) hydrogel has
an excellent network-like surface morphology. The potential pH-responsive
high swelling behavior and excellent shrinking features suggest the
reversible nature of the synthesized gel. Besides, rheological analyses
affirm its excellent viscoelastic nature. This network gel is biodegradable
and its non-cytotoxic nature toward human dermal fibroblast cells
is demonstrated. Moreover, the dual drug release pattern from the
copolymer under both in vitro and in vivo conditions portrays that
this hydrogel has superior ability to be used as a controlled release
matrix for both hydrophobic and hydrophilic drugs (TCH and IB) with
varying solubilities concurrently.